University at Buffalo School of Nursing researchers have identified a new benefit of mindfulness for people managing chronic ...

Chronic Obstructive Pulmonary disease (COPD) has been around for almost 205 years and is one of the most prevalent non-infectious diseases in our country. It is the 2nd leading cause of death and ...

A new research study highlights the significant health risks associated with dust storms, revealing an increase in emergency department (ED) visits for respiratory and cardiovascular conditions ...

Recent research published in The Lancet Respiratory Medicine confirms that emphysema was detected in 24% to 31% of patients undergoing lung cancer screening. This means that for millions of Americans, ...

Key findings• This study investigated the U-shaped nonlinear relationship between admission oxygen saturation (SpO2) and ...

Every year, 900,000 Americans are caught by surprise by the symptoms of a pulmonary embolism: a sudden shortness of breath, ...

GSK plc has announced that the China National Medical Products Administration has accepted for review the new drug ...

Upstream Bio is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. The Company is developing verekitug, the ...

Understanding resilience - the ability of injured lung tissue to heal and regenerate - may be key to advancing the treatment ...

and airway remodeling associated with chronic obstructive pulmonary disease (COPD). Selective PDE4 inhibition is proposed to maximize the antiinflammatory effects of PDE inhibition while ...